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What’s New: The impact of provider discussion formats over time on childhood immunization 
status is unknown. We found that presumptive (vs. participatory) formats used at the 2, 4, and/or 











































Objective: Presumptive formats to initiate childhood vaccine discussions (e.g. “Well we have to 
do some shots.”) have been associated with increased vaccine acceptance after one visit 
compared to participatory formats (e.g. “How do you feel about vaccines?”). We characterize 
discussion format patterns over time and the impact of their repeated use on vaccine acceptance. 
Methods: We conducted a longitudinal prospective cohort study of children of vaccine-hesitant 
parents enrolled in a Seattle-based integrated health system. After the child’s 2, 4, and 6 month 
visits, parents reported the format their child’s provider used to begin the vaccine discussion 
(presumptive, participatory, or other). Our outcome was the percentage of days under-immunized 
of the child at 8 months old for 6 recommended vaccines. We used linear regression and 
generalized estimating equations to test the association of discussion format and immunization 
status.  
Results: We enrolled 73 parent/child dyads and obtained data from 82%, 73%, and 53% after the 
2, 4, and 6 month visits, respectively. Overall, 65% of parents received presumptive formats at 
≥1 visit and 42% received participatory formats at ≥1 visit. Parental receipt of presumptive 
formats at 1 and ≥2 visits (vs. no receipt) was associated with significantly less under-
immunization of the child, while receipt of participatory formats at ≥2 visits was associated with 
significantly more under-immunization. Visit-specific use of participatory (vs. presumptive) 
formats was associated with a child being 10.1% (95% CI: 0.3, 19.8; P=.04) more days under-
immunized (amounting to, on average, 98 more days under-immunized for all 6 vaccines 
combined).  
Conclusions: Presumptive (vs. participatory) discussion formats are associated with increased 
immunization. 
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Parental refusal or delay of childhood vaccines is both prevalent
1-3
 and a key contributor 
to the persistence of outbreaks of vaccine-preventable disease (VPD).
4
 Parental vaccine refusal 







 As a result, increasing parent acceptance of childhood 
vaccines to reduce VPD is a top public health priority in the US.
10
  
The identification of provider communication strategies that are effective at improving 
parental acceptance of childhood vaccines is critical to addressing this priority. Pediatric 
providers are consistently cited by parents as the most important influence on their vaccine 
decision-making.
11
 In addition, parents report changing their mind about delaying or refusing a 
vaccine after their child’s provider addressed their concerns or gave them reassurance.
1,12
  
In previous work, we identified the format used to initiate the childhood vaccine 
discussion as a potentially effective vaccine communication strategy.
13-15
 In particular, provider 
use of presumptive (e.g. “Well we have to do some shots.”) rather than participatory (e.g. “How 
do you feel about vaccines today?”) formats was associated with increased parental vaccine 
acceptance of childhood vaccines.
13,14
 Limitations of this previous work, however, included 
observing only a single vaccine visit and measuring parental verbal acceptance of vaccines rather 
than actual child immunization status. In the present study, we sought to address these limitations 
by characterizing provider discussion format over time and its association with a child’s 
immunization status. We hypothesized that use of presumptive formats for initiating the 
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 We conducted a longitudinal prospective cohort study from August 2014 – March 2017 
in which we followed children of vaccine-hesitant parents (VHPs) over 3 health supervision 
visits at an integrated health care delivery organization (Group Health; GH) that covers 
approximately 600,000 members in Washington and Idaho states (in February 2017, GH became 
Kaiser Permanente). We associated parent-reported provider discussion format of the childhood 
vaccine discussion during these visits with the timeliness of immunizations received by the child 
by 8 months of age. The GH Human Subjects Review Committee formally reviewed and 
approved all study procedures, and the Washington State Institutional Review Board formally 
reviewed and approved study procedures involving Washington State Immunization Information 
System (WAIIS) data. 
 
Study Participants 
 Trained research assistants approached parents of singleton newborns born at ≥35 weeks 
gestational age either in-person prior to discharge from the GH newborn nursery in Seattle, WA 
or by phone within 6 weeks of their child’s birth to participate in a study about how doctors and 
parents talk about vaccines. Phone recruitment was used exclusively after the nursery closed in 
January 2015. Parents were eligible if they were a) ≥18 years old, b) English-speaking, c) GH 
members planning to have their child receive health supervision through 8 months of age with a 
GH pediatrician or family physician as well as accompany their child to the 2, 4, and 6 month 
health supervision visits, and d) a VHP (defined as a score of ≥50 [on a 0-100 scale] on the 
validated Parent Attitudes about Childhood Vaccines [PACV] survey administered at the time of 
enrollment, consistent with previous studies in which PACV scores ≥50 were associated with 
significantly higher under-immunization compared to scores <50
2,3
). We restricted eligibility to 
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VHPs because they represent an important population for interventions aimed at improving 
vaccine acceptance.
16
 We included only parents of newborns in order to focus on provider 
vaccine communication behaviors used at the first health supervision visits when the majority of 
the primary series of recommended vaccines begin.
17
 Lastly, we excluded parents who planned 
to have another person (e.g. a grandparent) solely accompany the child to a visit since there was 
no reliable way to follow up with non-parents. Parents provided written informed consent upon 
in-person enrollment and oral consent upon phone enrollment.  
 
Instrument Development and Evaluation 
 Prior to the start of the study, we developed and validated a parent self-report instrument 
to identify the format their child’s doctor used to initiate the vaccine discussion. All instrument 
items were written according to accepted guidelines for survey development,
18
 formatted 
according to accepted criteria for reducing non-response and avoiding measurement error,
19
 and 
initially revised after pretesting with a convenience sample of 44 English-speaking parents. We 
revised the instrument further (e.g. response categories for each initiation format listed were 
changed from a 5-point Likert scale from strongly agree to strongly disagree to ‘choose only 
one’) and created a telephone script to accompany its administration to improve its accuracy after 
further pretesting it with VHPs (N=20).  
 We tested the accuracy of the final version of the parent self-report instrument (Appendix 
1) by administering it to a separate cohort of VHPs (N=77) of 1-19 month old children after a 
videotaped health supervision visit with one of 17 participating pediatric providers at 12 non-GH 
Seattle primary care practices. Of these 77 VHPs, 49 were administered the instrument via phone 
within 3 days of the visit. This validation study was described generally to parents as one seeking 
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to understand how their child’s doctor talks with them during their child’s check-up in order to 
minimize the likelihood that participants altered their behavior to meet observer expectations. 
We compared parent-reported discussion format to the gold standard of observed discussion 
format using the videotapes of the same visits. Two of us (DJO, JDR) separately coded 
videotaped encounters using our previously developed interaction coding scheme for the 
childhood vaccine discussion
13,20
 and then met to compare coding. We used the kappa statistic 
(k) to measure inter-rater agreement.
21
 After the first 20% of encounters, a k of ≥0.7 was reached, 
suggesting greater than moderate agreement.
22
 The remaining encounters were coded by the 
principal investigator (DJO), with a second investigator (JDR) co-coding a random selection of 
encounters to ensure coding accuracy. The accuracy of the phone-administered parent instrument 
in identifying provider use of participatory and presumptive discussion formats was 77% (95% 
Confidence Interval [CI]: 60%, 90%).  
 
Data Collection 
Parent demographics were collected at baseline, including parent age, relationship to 
child, marital status, educational level, household income, ethnicity, race, and number of children 
in the household. Using computer-assisted telephone interviewing software and standardized 
interview procedures
23
 consistent with those developed and used during the validation study of 
the parent self-report instrument, trained research assistants administered the instrument to 
enrolled parents 7 days a week beginning the day of their child’s 2, 4, and 6 month health 
supervision visits. Similar to the validation study of the instrument, the initial attempts for 
contacting parents by phone were made within 3 days of their child’s visit in order to minimize 
measurement error resulting from recall bias,
24
 with the window for contacting parents ending 1 
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week post-visit. The average number of days from visit to phone call was 2.4 days for the 2 
month visit, 2.1 days for the 4 month visit, and 3.2 days for the 6 month visit. There were 12 
instances in which the 1 week window was exceeded because parents called back outside this 
timeframe after our final attempt to reach them was made on or before day 7. There was no 
change in our results when excluding these late interviews, so they were retained. With each 
post-visit call, research assistants confirmed that the child of the enrolled parent just completed a 
health supervision visit and that the parent accompanied the child to the visit. Parents were also 
asked whether shots were discussed at the visit, and for those who responded no, questions about 
the format used to initiate the vaccine discussion were skipped. Lastly, whether the visit was 
with the child’s regular doctor and whether a first-time vaccine discussion with the doctor 
occurred was also recorded because these factors may influence provider communication 





When a child of an enrolled parent reached 8 months, 0 days, we assessed their 
immunization status using their GH electronic immunization record for each of the 16 doses of 
the 6 vaccines recommended at that age since birth: 2 doses of hepatitis B vaccine, 3 doses of 
rotavirus vaccine, 3 doses of diphtheria, tetanus toxoids, and acellular pertussis vaccine, 3 doses 
of Haemophilus influenzae type b vaccine, 3 doses of pneumococcal conjugate vaccine, and 2 
doses of inactivated poliovirus vaccine.
17
 GH immunization records have been electronic since 
1991, have been updated from the GH electronic medical record system since 2005, and receive 
data from WAIIS monthly on vaccinations received outside GH to ensure completeness.
25
 GH 
immunization records are also typically updated with WAIIS data on patients who dis-enroll 
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from GH until the patient joins a new health plan. However, to ensure immunization record 
accuracy, we separately obtained WAIIS data of child participants whose parents provided data 
from at least 1 visit and didn’t remain continuous GH members (defined as a <63 day gap in 
membership from enrollment until 8 months old of age) in order to perform an additional cross-
reference with GH immunization records.  
We expressed child immunization status as the percentage of days under-immunized 
from birth to 8 months, 0 days for all 6 vaccines combined using a method adapted from a prior 
study.
26
 This measure captures both refusal and delay in receipt of recommended doses by 
calculating the difference between the age in days the dose was received and the latest age in 
which it should have been received according to the recommended immunization schedule. If a 
dose was never received, the maximum number of days late a child could be for that dose was 
their age in days at 8 months, 0 days (244 days) minus the latest age in days in which that dose 
should have been received. To obtain the percentage of days under-immunized from 0 – 8 
months, we summed the days late for each dose of the 6 vaccines and divided this by the 
maximum number of days a child could be late if they had received none of the total 16 doses for 
the 6 vaccines by 8 months (967 days). We calculated the percentage of days under-immunized 
from birth to 4 months, 0 days and birth to 6 months, 0 days in the same manner to determine the 
maximum number of days a child could be late if they had received none of the recommended 
doses for the 6 vaccines by 2 months (235 days) and 4 months (601 days), respectively. Lastly, to 
account for use of a catch-up immunization schedule after a first late dose, we performed a 
lenient calculation of days under-immunized by adding 28 additional days to the minimum 
interval number of days between doses for that vaccine.  
 




 For all analyses, the child was the unit of analysis. Our primary exposure variable was the 
parent-reported discussion format providers used to initiate the childhood vaccine discussion, 
categorized as presumptive, participatory, or other (Appendix 1). We used descriptive statistics 
to summarize parent and visit characteristics as well as our predictor and outcome variables at 
each time point and overall. We assessed the bivariate relationships between parent and visit 
characteristics and our predictor variable using Pearson’s χ
2
 tests (or Fisher’s exact tests) and 
these same characteristics and our outcome variable using t-tests. In these analyses, we 
dichotomized PACV scores as 50-69 and 70-100, consistent with a prior PACV validation study 
in which higher under-immunization was associated with higher PACV score tier.
3
 We also 
assessed for a dose-response relationship between immunization status and number of visits 
(categorized as 0, 1, or ≥2 visits) in which a parent was exposed to presumptive or participatory 
formats by performing a nonparametric test for trend across both groups. 
Parent and visit characteristics that were associated (P<0.10) with discussion format and 
immunization status in bivariate analysis and were not narrowly distributed
27
 were retained in 
multivariate models (parent age, race). We also included variables selected a priori as potential 
confounders (first-time vaccine discussion, child birth order).
13,14,28
 We used linear regression to 
test the association of the number of visits (with 0 visits as the referent group) in which a parent 
was exposed to a particular discussion format and percent days under-immunized at 8 months 
after accounting for parent and visit characteristics. Since there was no significant association 
found between exposure to ‘other’ formats and immunization status, we only present regression 
results from exposure to presumptive and participatory formats. Also, we found no significant 
difference when using the lenient calculation of the percentage of days under-immunized, so we 
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only present regression results using the standard calculation. Lastly, we examined the 
association between the use of a participatory (vs. presumptive) format and immunization status 
at each visit. For these inferences, we applied generalized estimating equations and robust 





 We enrolled 73 parent/child dyads and obtained data from 82%, 73%, and 53% of 
participants after the 2, 4, and 6 month visits, respectively (Figure 1). Among parent participants, 
92% were mothers, 69% were > 30 years old, and 58% were white (Table 1). The primary 
reasons for lost to follow-up were that child participants never had subsequent health supervision 
visits after enrollment or parent participants were unable to be reached by phone after a visit. 
Overall, 92% (N=67) of parent participants provided discussion format data from ≥1 visit and 
25% (N=18) from all 3 visits.  
At each time point, presumptive formats were most frequently used and ‘other’ formats 
the least frequently used (Figure 2), with these ‘other’ formats consisting primarily of parent 
(rather than doctor) initiated formats (e.g. “I brought it up” or “I started to talk about the shots 
before my doctor did”). Among parents with discussion format data from ≥1 visit, 40% (N=27) 
were exposed only to presumptive formats, 16% (N=11) only to participatory formats, and 10% 
(N=7) to other formats; 33% (N=22) were exposed to a mix of discussion formats. There were 
65% of parents (N=44) who received presumptive formats at ≥1 visit and 42% (N=28) who 
received participatory formats at ≥1 visit. A significantly higher proportion of White (vs. non-
White) parents (49% vs. 15%; P=.008) and parents ≥30 years old (vs. <30 years old; 49% vs. 
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14%; P=.03) had 0 visits involving presumptive formats, and a significantly higher proportion of 
mothers (vs. non-mothers; 69% vs. 0%; P=.007) had 0 visits involving participatory formats. 
Child participants were under-immunized for a mean of 39.2% of days between birth and 
8 months of age (standard deviation: 41.2), with 19% remaining completely un-immunized. 
White (vs. non-White) parents had children who were significantly more under-immunized at 8 
months of age (mean values of 51.9% [95% CI: 39.0%, 64.9%] vs. 24.3% [95% CI: 10.7%, 
37.9%], respectively; P=.005), and Hispanic (vs. non-Hispanic) parents had children who were 
significantly less under-immunized at 8 months of age (mean values of 16.5% [95% CI: 2.3%, 
30.6%] vs. 43.2% [95% CI: 32.3%, 54.0%], respectively; P=.046). Only PACV score was 
associated with being completely unimmunized at 8 months of age, with a higher proportion of 
parents who scored 70-100 (vs. 50-69) having an un-immunized child at 8 months of age (40% 
vs. 8.3%, respectively; P=.003). Use of participatory (vs. presumptive) formats at the 2 month 
visit was associated with a child being more under-immunized after the 2 month visit (means of 
60.7% [95% CI: 39.9%, 81.5%] vs. 25.7% [95% CI: 13.1%, 38.3%], respectively; P=.003) and 
there was a higher proportion of providers who used participatory (vs. presumptive) formats at 
the 4 or 6 month visits with parents who had children who were completely un-immunized after 
the 2 month visit (30% vs. 5%, respectively; P=.02).  
There was a dose-response relationship between immunization status and the number of 
visits involving presumptive formats, with significantly less under-immunization associated with 
an increasing number of visits involving presumptive formats (P=.003). There was also a dose-
response relationship between immunization status and the number of visits involving 
participatory formats, with significantly more under-immunization associated with an increasing 
number of visits involving participatory formats (P=.001). In unadjusted regression analyses, 
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children of parents exposed to 1 and ≥2 visits involving presumptive formats were significantly 
less under-immunized from birth to 8 months of age compared to children of parents who were 
exposed to 0 visits (Figure 3). Correspondingly, children of parents exposed to 1 and ≥2 visits 
involving participatory formats were significantly more under-immunized from birth to 8 months 
of age compared to children of parents who were exposed to 0 visits. After adjusting for 
demographic and visit characteristics, these associations remained significant except for parents 
exposed to only 1 visit involving participatory formats. Among all parents, visit-specific use of 
participatory (vs. presumptive) formats was associated with a child being on average 10.1% 
(95% CI: 0.3, 19.8; P=.04) more days under-immunized. 
 
Discussion 
 Our finding that presumptive (vs. participatory) formats to initiate the childhood vaccine 
discussion are associated with increased immunization over several visits is consistent with our 
previous results obtained after observing single encounters.
13-15
 It is also consistent with recent 
results in the adolescent vaccine context.
30,31
 Taken together, these studies suggest that 
presumptive formats for initiating the vaccine discussion are a more effective communication 
strategy than participatory formats for improving parental vaccine acceptance. 
Our results are also noteworthy because of previous concerns that presumptive formats to 
initiate vaccine discussions may result in decreased vaccine uptake over time by eroding trust or 
generating feelings of resentment.
32
 There are several possible explanations for why we did not 
find decreased vaccine uptake with the repeated use of presumptive formats. First, presumptive 
formats establish vaccine acceptance as the reference point, or default, for parents’ decision-
making. Defaults themselves are influential because they leverage several cognitive biases 
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underlying human decision-making, such as omission and status quo biases,
33
 which make it 
difficult to depart from default reference points.
34
 It may be that these cognitive biases simply 
prevail in their influence on parental vaccination behavior over other counteracting factors, such 
as feelings of resentment. Second, presumptive formats need not feel presumptive to parents. 
Rather, they can be delivered using a variety of positive interpersonal skills, such as sitting at the 
same level as parents, maintaining eye contact, using a non-judgmental tone, speaking in an 
unhurried manner, and allowing parents to respond.
35
 It may be that providers in our study used 
these techniques when employing presumptive formats, thereby minimizing any negative impact 
these initiations might have on factors important to vaccine acceptance, such as trust. Lastly, it is 
possible that vaccine uptake is indeed negatively affected but follow-up beyond 8 months is 
needed for this effect to be detectable or a longer exposure to presumptive formats (i.e. more 
than 3 visits) is required. However, this seems unlikely since the 3 visits we observed include the 
majority of the primary series of vaccines.  
We also found that more providers used participatory (vs. presumptive) formats in 
subsequent visits with parents who had children who were completely un-immunized after the 2 
month visit. This is perhaps not surprising because it can feel awkward to begin a subsequent 
vaccine conversation with a parent who has previously refused vaccines for their child by 
presuming the parent will now accept them. The importance of beginning the vaccine discussion 
in these scenarios with a vaccine recommendation, however, deserves further study. 
There are several limitations to this study. First, although provider discussion format was 
measured using a reasonably accurate parent-report instrument, there was likely still some 
residual measurement error. We did explore whether accuracy of parent-report was associated 
with parent socio-demographic factors (age, gender, race, education, household income, marital 
Page 14 of 25
15 
 
status, and number of children in the household) and found none to be statistically significant. 
Second, there was attrition over the course of the study resulting in missing data from 30% of 
observations. This attrition may have been exacerbated by the acquisition of GH by Kaiser 
Permanente, which was announced in the middle of our study (December 2015) and created 
uncertainty among GH membership.
36
 To assess for bias introduced by this attrition, we 
compared parent demographics and visit characteristics among participants with discussion 
format data from all 3 time points (N=18) with those who had missing data from at least one visit 
(N=55) and found no significant differences. Third, given our non-randomized study design, 
there may be unmeasured variables that are driving the observed association between use of 
participatory discussion formats and under-immunization. We conducted a sensitivity analyses in 
which we excluded parents with children who were completely un-immunized at 8 months, 
under the assumption that some of these unmeasured variables may be factoring more 
prominently with these parents. Our results, however, were similar: parents exposed to ≥2 visits 
involving participatory formats still had children who remained significantly more under-
immunized at 8 months of age compared to parents exposed to 0 visits involving participatory 
formats (mean of 36.9%, 95% CI: 11.7, 62.1; P=.005). Fourth, the clinical significance of being 
10.1% more days under-immunized from birth to 8 months—which amounts to, on average, 98 
more days under-immunized for all 6 vaccines combined—is unclear since the risk of disease 
due to delay varies by vaccine/vaccine-preventable disease. However, under-immunized children 
are at some increased risk
8
 and missing early doses in a vaccine series is associated with missing 
later ones,
37
 contributing to more under-immunization over time. Lastly, we conducted our study 
at a single US institution, and therefore our results may not be generalizable. 
 




Presumptive formats for initiating the childhood vaccine discussion were associated with 
increased immunization over time. Though these results require confirmation using a randomized 
trial study design, they add to the growing evidence-base for the effectiveness of presumptive 
initiation formats in the vaccine context. Studies are needed to evaluate the implementation of 
the presumptive format in clinical practice as well as interventions that combine the presumptive 
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2 month visit (N=60; 82%)* 
 
 
 Ineligible (N=2451) 
 No follow-up at GH (N=844) 
 Not vaccine-hesitant (N=1555) 
 Other (N=54) 
 Refused (N=1579) 
 Ineligible because no follow-up 
at GH (N=26) 
 
  Unable to be reached (N=9) 
 Cancelled appointment (N=2) 
 Eligible parent did not attend 
appointment (N=2) 
4 month visit (N=53; 73%)* 
 
 
6 month visit (N=39; 53%)* 
 
 
 Unable to be reached (N=6) 
 Cancelled appointment (N=1) 
 Eligible parent did not attend 
appointment (N=3) 
 No appointment made (N=9) 
 Survey incomplete (N=1) 
 Unable to be reached (N=9) 
 Eligible parent did not attend 
appointment (N=2) 
 No appointment made (N=22) 
 Survey incomplete (N=1) 
*Of these 152 total data points from the 2, 4 and 6 month visits, there were 19 
instances (12%) in which no initiation format data was obtained because the 
parent reported that no shots were discussed (and therefore the initiation format 
questions were skipped). Of the remaining 133 data points, there were 2 instances 
(1%) in which the parent couldn’t remember the initiation format used or 
responded that shots were not needed (responses 4 and 5 in Appendix A). 
Therefore, 131 data points were included in analysis. 
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Table 1. Parent and Visit Characteristics (N=73) 
Characteristic N (%) 
Relationship to Child 
Mother 67 (92) 
Parent Marital Status 
















American Indian/Alaskan Native 2 (3) 
Asian 4 (6) 
Black or African American 3 (4) 
Native Hawaiian or other Pacific Islander 2 (3) 
White 41 (58) 
More than one race 16 (22) 
Other 3 (4) 
Parent Ethnicity 
Hispanic 11 (15) 
No. Children in Household 
1 34 (47) 
Child birth order 
First born 37 (51) 
First-time vaccine discussion 
At 2 month visit^ 32 (58) 
At 4 month visit^ 11 (26) 
At 6 month visit^ 6 (19) 
Saw child’s regular doctor 
At 2 month visit^ 52 (88) 
At 4 month visit^ 42 (79) 
At 6 month visit^ 32 (82) 
PACV Score: mean (range) 63.4 (50-93.3) 
50-69 48 (66) 
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Appendix 1. Parent-report instrument to identify the type of communication format 
providers used to initiate the childhood vaccine discussion 
 
(Item Introduction) For this question, I will read you several scenarios. After I read them, please 
choose the one that best describes what happened during your visit. 
 
1 AT THIS VISIT, your child’s doctor STARTED to talk about the plan for shots by 
TELLING you which shots your child would be getting without asking your opinion. 
  
For example, if your child’s doctor FIRST started to talk about the plan for shots by 
saying something like “Well, we have to do some shots.” or “He’s due for DTaP, Hib 
and IPV today.”, choose this response. He or she simply told you what the plan was 
and didn’t ask you how you felt about that plan. 
2 AT THIS VISIT, your child’s doctor STARTED to talk about the plan for shots by 
TELLING you which shots your child would be getting and then ASKING your 
opinion about that shot plan.  
 
For example, if your child’s doctor FIRST started to talk about the plan for shots by 
saying something like “So, he’s due for three shots today. Is that OK with you?”, 
choose this response. In this instance, he or she told you what the plan was but then 
asked you what you thought about it. 
3 AT THIS VISIT, your child’s doctor STARTED to talk about the plan for shots by 
ASKING you what you wanted to do about shots.  
 
For example, if your child’s doctor FIRST started to talk about the plan for shots by 
saying something like “How do you feel about shots?” or “Are we going to do shots 
today?”, choose this response. 
4 You don’t remember how your child’s doctor started talking about shots AT THIS 
VISIT.  
 
5 Your child didn’t need any shots AT THIS VISIT. 
 
6 None of the above. [interviewer write verbatim what parent said] 
 
For example, if you started to talk about the plan for shots first BEFORE your child’s 
doctor did, such as by saying “So we wanted to just do a few shots today” or “We’re 
going on vacation tomorrow so I think I would like to get all the vaccines today”, you 
would choose this response.  
Footnote: Responses 1 and 2 were coded as presumptive formats, response 3 as participatory 
format, and response 6 as ‘other’ format. Responses 4 and 5 were excluded as missing data. 
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